Literature DB >> 33864569

Human umbilical cord-derived mesenchymal stem cells and their chondroprogenitor derivatives reduced pain and inflammation signaling and promote regeneration in a rat intervertebral disc degeneration model.

Sobia Ekram1, Shumaila Khalid1, Imtiaz Bashir2, Asmat Salim1, Irfan Khan3.   

Abstract

Intervertebral disc (IVD) degeneration is an asymptomatic pathophysiological condition and a strong causative factor of low back pain. There is no cure available except spinal fusion and pain management. Stem cell-based regenerative medicine is being considered as an alternative approach to treat disc diseases. The current study aimed to differentiate human umbilical cord-mesenchymal stem cells (hUC-MSCs) into chondrocyte-like cells and to elucidate their feasibility and efficacy in the degenerated IVD rat model. Chondrogenic induction medium was used to differentiate hUC-MSCs into chondroprogenitors. Rat tail IVD model was established with three consecutive coccygeal discs. qPCR was performed to quantify the molecular markers of pain and inflammation. Histological staining was performed to evaluate the degree of regeneration. Induced chondroprogenitors showed the expression of chondrogenic genes, SOX9, TGF-β1, ACAN, BMP2, and GDF5. Immunocytochemical staining showed positive expression of chondrogenic proteins SOX9, TGF-β1, TGF-β2, and Collagen 2. In in vivo study, transplanted chondroprogenitors showed better survival, homing, and distribution in IVD as compared to normal MSCs. Expression of pain and inflammatory genes at day 5 of cell transplantation modulated immune response significantly. The transplanted labeled MSCs and induced chondroprogenitors differentiated into functional nucleus pulposus (NP) cells as evident from co-localization of red (DiI) and green fluorescence for SOX9, TGF-β1, and TGF-β2. Alcian blue and H & E staining showed standard histological features, indicating better preservation of the NP structure and cellularity than degenerated discs. hUC-MSCs-derived chondroprogenitors showed better regeneration potential as compared to normal MSCs. The pain and inflammation genes were downregulated in the treated group as compared to the degenerated IVD.

Entities:  

Keywords:  Chondroprogenitor cells; Gene expression; Inflammation; Intervertebral disc; Mesenchymal stem cells; Pain; Regeneration

Year:  2021        PMID: 33864569     DOI: 10.1007/s11010-021-04155-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mohamad Bydon; Rafael De la Garza-Ramos; Mohamed Macki; Abdul Baker; Aaron K Gokaslan; Ali Bydon
Journal:  J Spinal Disord Tech       Date:  2014-07

2.  Short-term outcomes of lateral lumbar interbody fusion without decompression for the treatment of symptomatic degenerative spondylolisthesis at L4-5.

Authors:  Peter G Campbell; Pierce D Nunley; David Cavanaugh; Eubulus Kerr; Philip Andrew Utter; Kelly Frank; Marcus Stone
Journal:  Neurosurg Focus       Date:  2018-01       Impact factor: 4.047

3.  Transplantation of CXCR4 Overexpressed Mesenchymal Stem Cells Augments Regeneration in Degenerated Intervertebral Discs.

Authors:  Ji-Nan Wei; Feng Cai; Feng Wang; Xiao-Tao Wu; Lei Liu; Xin Hong; Wen-Hao Tang
Journal:  DNA Cell Biol       Date:  2016-01-20       Impact factor: 3.311

4.  Mesenchymal Stem Cell-Seeded High-Density Collagen Gel for Annular Repair: 6-Week Results From In Vivo Sheep Models.

Authors:  Ibrahim Hussain; Stephen R Sloan; Christoph Wipplinger; Rodrigo Navarro-Ramirez; Micaella Zubkov; Eliana Kim; Sertac Kirnaz; Lawrence J Bonassar; Roger Härtl
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

5.  Form and function of the intervertebral disc in health and disease: a morphological and stain comparison study.

Authors:  B A Walter; O M Torre; D Laudier; T P Naidich; A C Hecht; J C Iatridis
Journal:  J Anat       Date:  2014-11-25       Impact factor: 2.610

6.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

7.  Characterization of the age-dependent intervertebral disc changes in rabbit by correlation between MRI, histology and gene expression.

Authors:  Johann Clouet; Marianne Pot-Vaucel; Gaël Grimandi; Martial Masson; Julie Lesoeur; Borhane H Fellah; Olivier Gauthier; Marion Fusellier; Yan Cherel; Yves Maugars; Jérôme Guicheux; Claire Vinatier
Journal:  BMC Musculoskelet Disord       Date:  2011-07-04       Impact factor: 2.362

8.  Intervertebral Disc Tissue Engineering with Natural Extracellular Matrix-Derived Biphasic Composite Scaffolds.

Authors:  Baoshan Xu; Haiwei Xu; Yaohong Wu; Xiulan Li; Yang Zhang; Xinlong Ma; Qiang Yang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 9.  Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease: A Systematic Review of Animal Studies and Human Clinical Trials.

Authors:  David Oehme; Tony Goldschlager; Peter Ghosh; Jeffrey V Rosenfeld; Graham Jenkin
Journal:  Stem Cells Int       Date:  2015-05-14       Impact factor: 5.443

10.  The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model.

Authors:  Yan Zhang; Hui Tao; Tao Gu; Mingyue Zhou; Zhiwei Jia; Gangqiang Jiang; Chun Chen; Zhihua Han; Cheng Xu; Deli Wang; Qing He; Dike Ruan
Journal:  Stem Cell Res Ther       Date:  2015-08-27       Impact factor: 6.832

View more
  7 in total

Review 1.  Current Insights Into the Maintenance of Structure and Function of Intervertebral Disc: A Review of the Regulatory Role of Growth and Differentiation Factor-5.

Authors:  Bin Lv; Weikang Gan; Zhangrong Cheng; Juntao Wu; Yuhang Chen; Kangchen Zhao; Yukun Zhang
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

2.  Decellularized Human Umbilical Tissue-Derived Hydrogels Promote Proliferation and Chondrogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Faiza Ramzan; Sobia Ekram; Trivia Frazier; Asmat Salim; Omair Anwar Mohiuddin; Irfan Khan
Journal:  Bioengineering (Basel)       Date:  2022-05-30

Review 3.  Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications.

Authors:  E Russo; M Caprnda; P Kruzliak; P G Conaldi; C V Borlongan; G La Rocca
Journal:  Stem Cells Int       Date:  2022-01-06       Impact factor: 5.443

Review 4.  The role of microenvironment in stem cell-based regeneration of intervertebral disc.

Authors:  Genglei Chu; Weidong Zhang; Feng Han; Kexin Li; Chengyuan Liu; Qiang Wei; Huan Wang; Yijie Liu; Fengxuan Han; Bin Li
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

5.  Global research status and hot trends in stem cells therapy for Intervertebral disc degeneration: A bibliometric and clinical study analysis.

Authors:  Nan Wang; Shuang Chen; Xiaoyu Zhang; Zhipeng Xi; Xiaoyang Fang; Congyang Xue; Jingchi Li; Lin Xie
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

Review 6.  Recent Advances in Monitoring Stem Cell Status and Differentiation Using Nano-Biosensing Technologies.

Authors:  Wijin Kim; Eungyeong Park; Hyuk Sang Yoo; Jongmin Park; Young Mee Jung; Ju Hyun Park
Journal:  Nanomaterials (Basel)       Date:  2022-08-25       Impact factor: 5.719

Review 7.  Regulating the fate of stem cells for regenerating the intervertebral disc degeneration.

Authors:  Sobia Ekram; Shumaila Khalid; Asmat Salim; Irfan Khan
Journal:  World J Stem Cells       Date:  2021-12-26       Impact factor: 5.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.